跳至主要内容
临床试验/EUCTR2009-013378-42-IT
EUCTR2009-013378-42-IT进行中(未招募)不适用

Double-blind, placebo-controlled, randomised clinical study of Broncho-Vaxom drops in children suffering from recurrent respiratory tract infections - EBV09/01

OM PHARMA0 个研究点目标入组 278 人开始时间: 2010年9月10日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
278

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Children of both genders, age between 1 and 6 years (included in their 7th year), history of recurrenty respiratory tract infections (minimum 4 documented episodes during the previous year), suffering from a RTI at the enrolment visit, parent(s) or legal representative having given their written informed consent.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Tonsillectomy and/or adenoidectomy if performed after the first RTI during the year preceding the study period, allergic ashma, mucoviscidosis,significant systemic diseases (i.e. hepatic and/or renal), auto-immune or immune system related diseases, oral vaccination with live vaccine within 4 weeks before study start, participation in another clinical trial within the last month.

研究者

发起方
OM PHARMA

相似试验

进行中(未招募)
不适用
Double-blind, placebo-controlled, randomised clinical study of Broncho-Vaxom® drops in children suffering from recurrent Respiratory Tract Infections (RTIs) - Broncho-Vaxom® drops in children with recurrent RTIsRecurrent respiratory tract infectionsMedDRA version: 12.0Level: LLTClassification code 10038133Term: Recurrent respiratory tract infections
EUCTR2009-013378-42-HUOM PHARMA278
进行中(未招募)
不适用
Double-blind, placebo-controlled, randomised clinical study ofBroncho-Vaxom® in children suffering from recurrent upper respiratory tract infections - Broncho-Vaxom® in children with recurrent URTIs
EUCTR2006-002980-17-CZOM PHARMA420
进行中(未招募)
不适用
Study intentended to prove effectivness and safety of use of Broncho-Vaxom drops in preventing repeated respiratory tract infections in childern.Recurrent respiratory tract infections
EUCTR2009-013378-42-CZOM PHARMA SA278
进行中(未招募)
不适用
Double-blind, placebo-controlled, randomised clinical study ofBroncho-Vaxom® in children suffering from recurrent upper respiratory tract infections - Broncho-Vaxom® in children with recurrent URTIsRecurrent upper respiratory tract infections in childrenMedDRA version: 9.1Level: LLTClassification code 10046306Term: Upper respiratory tract infection
EUCTR2006-002980-17-ATOM PHARMA420
进行中(未招募)
1 期
Double-blind, placebo-controlled, randomised clinical study of Broncho-Vaxom® drops in children suffering from recurrent Respiratory Tract InfectionsRecurrent respiratory tract infections
EUCTR2009-013378-42-BEOM PHARMA SA278